Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 4 4Phase 2 3Phase NA 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3Endocrine 2NET 1Breast 1

Conditions

Pancreatic Neuroendocrine Tumor G2 1

Interventions

lutetium Lu 177 dotatate 2Lutetium-177 2Liquid Biopsy 2Endoscopic Mucosal Resection 2Data Collection 2pentetreotide 1fluorodopa F 18 1copper dotatate CU-64 1Yttrium-90 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Standard of Care 1Specimen Handling 1Single Photon Emission Computed Tomography Computed Tomography 1Serum Albumin 1Robotic Surgical Procedures 1Resveratrol 1Respiratory Therapy 1Referral and Consultation 1Radiofrequency Ablation 1Quality of Life 1Poly(ADP-ribose) Polymerase Inhibitors 1Palliative Care 1Octreotide 1Nutrition Assessment 1Needles 1Magnetic Resonance Spectroscopy 1Laparoscopy 1Drug Therapy 1Diet Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Octreotide × NET × Clear all
NCT06080204 2023-10-18

Real-world Study on Adjuvant Octreotide Therapy in pNETs

Changhai Hospital

Phase NA Completed
411 enrolled
EndocrineGastrointestinalNET

Pancreatic Neuroendocrine Tumor G2

Data powered by HemOnc (CC BY 4.0) Colophon âš¡